BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 4958598)

  • 1. The effect of enzymatic release of sialic acid from human erythrocytes on Rh agglutinations.
    Prager MD; Fletcher MA
    J Immunol; 1966 Aug; 97(2):165-70. PubMed ID: 4958598
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the effect of cholera neuraminidase in comparison with other neuraminic acid splitting enzymes of plant and animal origin on a few physico-chemical properties of human erythrocytes].
    Hummel K
    Pathol Microbiol (Basel); 1965; 28(6):891-900. PubMed ID: 4956349
    [No Abstract]   [Full Text] [Related]  

  • 3. On the possible relation of sialic acid to the Rh factor.
    Prager MD; Lowry ME
    Transfusion; 1966; 6(6):577-83. PubMed ID: 4959163
    [No Abstract]   [Full Text] [Related]  

  • 4. Further studies on the mechanism of the effect of enzymes on erythrocytes serology with special reference to pronase.
    Prager MD; Soules ML; Fletcher MA
    Transfusion; 1968; 8(4):220-5. PubMed ID: 4970375
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of sialic acid in hemagglutination.
    Khan MY; Zinneman HH
    Am J Clin Pathol; 1970 Nov; 54(5):715-9. PubMed ID: 4990861
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies of human erythrocytes by endless belt electrophoresis. I. A comparison of electrophoretic mobility with serologic reactivity.
    Sturgeon P; Kolin A; Kwak KS; Luner SJ
    Haematologia (Budap); 1972; 6(1):93-108. PubMed ID: 4623726
    [No Abstract]   [Full Text] [Related]  

  • 7. Impacts of papain and neuraminidase enzyme treatment on electrohydrodynamics and IgG-mediated agglutination of type A red blood cells.
    Hyono A; Gaboriaud F; Mazda T; Takata Y; Ohshima H; Duval JF
    Langmuir; 2009 Sep; 25(18):10873-85. PubMed ID: 19735140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of the enzymatic treatment of erythrocyte membranes on their interaction with neutrophilic leukocytes].
    Kaĭdashev IP; Katrushov AV; Mishchenko VP
    Fiziol Zh (1978); 1993; 39(1):19-23. PubMed ID: 8335120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of streptolysin S to red blood cell ghosts and ghost lipids.
    Elias N; Heller M; Ginsburg I
    Isr J Med Sci; 1966; 2(3):302-9. PubMed ID: 4289151
    [No Abstract]   [Full Text] [Related]  

  • 10. [Procedures for the determination of the total neuraminic acid content of erythocytes and tumor cells, as well as in the use of pronase in tissue culture].
    Uhlenbruck G; Sehrbundt HJ
    Bibl Haematol; 1969; 32():337-48. PubMed ID: 5822811
    [No Abstract]   [Full Text] [Related]  

  • 11. [Noteworthy chemical, serologic and electrokinetic phenomena in cat erythrocytes: a contrtibution to the determination and importance of mucoid and glycolipoid bound erythrocyte neuraminic acid].
    Uhlenbruck G; Rothe A; Pardoe GI
    Z Immunitatsforsch Allerg Klin Immunol; 1968 Jul; 136(1):79-97. PubMed ID: 4234970
    [No Abstract]   [Full Text] [Related]  

  • 12. Activating papain with unithiol in the ferment treatment of erythrocytes.
    Koutsarova T; Shkenderov S
    C R Acad Bulg Sci; 1967; 20(3):249-52. PubMed ID: 4971914
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemagglutination and the closest distance of approach of normal, neuraminidase- and papain-treated erythrocytes.
    van Oss CJ; Absolom DR
    Vox Sang; 1984; 47(3):250-6. PubMed ID: 6431697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative haemagglutination. 4. Effect of neuraminidase treatment on agglutination by blood group antibodies.
    Greenwalt TJ; Steane EA
    Br J Haematol; 1973 Aug; 25(2):207-15. PubMed ID: 4199348
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on trypsin treatment of red cells with special reference to differences between trypsin preparations.
    Heisto H; Jensen L; Knuds F
    Vox Sang; 1971 Aug; 21(2):115-25. PubMed ID: 5000957
    [No Abstract]   [Full Text] [Related]  

  • 16. Some observations on the T, Tn and Sda antigens and the antibodies that define them.
    Issitt PD; Issitt CH; Moulds J; Berman HJ
    Transfusion; 1972; 12(4):217-21. PubMed ID: 4402667
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of the immunohematologic effect of papain and related enzymes.
    PRAGER MD; FLETCHER MA; EFRON K
    J Immunol; 1962 Dec; 89():834-40. PubMed ID: 13985906
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnosis of "polyagglutinable" erythrocytes].
    Uhlenbruck G; Reifenberg U; Prokop O; Schnitzler S
    Acta Biol Med Ger; 1971; 26(2):405-9. PubMed ID: 5168994
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunological and electron microscopic analysis of IgG anti-D saline hemagglutination of neuraminidase-and protease-modified red cells.
    Masouredis SP; Sudora EJ; Victoria EJ
    J Lab Clin Med; 1977 Nov; 90(5):929-48. PubMed ID: 409796
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of proteases and neuraminidase on RBC surface charge and agglutination. A kinetic study.
    Luner SJ; Sturgeon P; Szklarek D; McQuiston DT
    Vox Sang; 1975; 28(3):184-99. PubMed ID: 164087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.